Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000132

Director sold 1,419 shares at $22.60 ($32,069)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krognes Steve E. Director 2023-08-21 Sale −1,419 $22.60 $32,069 145,799 D
Open-market sales · 1,419 sh · avg $22.60 · $32,069
Loading xslF345X05/wk-form4_1692822662.xml…